CN Patent

CN101068550B — 含有释放速度控制组分的羧酰胺人类免疫缺陷整合酶抑制剂药物制剂

Assigned to Merck Sharp and Dohme LLC · Expires 2011-03-30 · 15y expired

What this patent protects

本发明中描述了适用于以固体剂型口服给药的药物制剂。所述组合物包括有效量的式I化合物的碱式盐和包含增溶剂、胶凝剂和水溶性填料的释放速度控制组分；其中R 1 、R 2 、R 3 和R 4 如本文中所定义。所述制剂适用于HIV整合酶的抑制、HIV感染的治疗或者预防和AIDS发作的治疗、预防或者延迟中。

USPTO Abstract

本发明中描述了适用于以固体剂型口服给药的药物制剂。所述组合物包括有效量的式I化合物的碱式盐和包含增溶剂、胶凝剂和水溶性填料的释放速度控制组分；其中R 1 、R 2 、R 3 和R 4 如本文中所定义。所述制剂适用于HIV整合酶的抑制、HIV感染的治疗或者预防和AIDS发作的治疗、预防或者延迟中。

Drugs covered by this patent

Patent Metadata

Patent number
CN101068550B
Jurisdiction
CN
Classification
—
Expires
2011-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.